Substandard, falsified and unregistered medicines in Latin America, 2017-2018

OBJECTIVE. To assess all the incidents of substandard, falsified and unregistered medicines in 2017 and 2018 in Latin America, determining the types of products affected, stages of the supply chain in which incidents were detected, quality deviations identified in tested samples, and regulatory meas...

Descripción completa

Detalles Bibliográficos
Autor principal: Rojas-Cortés, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Organización Panamericana de la Salud 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537817/
https://www.ncbi.nlm.nih.gov/pubmed/33033498
http://dx.doi.org/10.26633/RPSP.2020.125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537817/
https://www.ncbi.nlm.nih.gov/pubmed/33033498
http://dx.doi.org/10.26633/RPSP.2020.125

Ejemplares similares